This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...

AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.

AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes ...

AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes ...

Here's why one generic for Lipitor and other recognizable brands may have missed the mark compared to its recognizable ...

Research published in JAMA Internal Medicine reveals statins may reduce liver cancer risk by 33% and liver complications by ...

Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be ...

One factor that may increase the risk of dementia is high levels of blood cholesterol. Now, a study has found that low levels ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

Study finds drugs may provide additional protection against neurological conditions and improve cardiovascular health ...

Subscribe here to receive future editions. The race to develop more convenient versions of drugs that lower cholesterol is heating up after AstraZeneca released encouraging new data on an ...